Dr Douglas Matthew Weine, MD in Red Bank, NJ - Medicare Gastroenterology

Dr Douglas Matthew Weine, MD is a medicare enrolled "Internal Medicine - Gastroenterology" physician in Red Bank, New Jersey. He graduated from medical school in 2004 and has 20 years of diverse experience with area of expertise as Gastroenterology. He is a member of the group practice Allied Digestive Health Llc and his current practice location is 365 Broad St, Red Bank, New Jersey. You can reach out to his office (for appointments etc.) via phone at (732) 842-4294.

Dr Douglas Matthew Weine is licensed to practice in New Jersey (license number 25MA08720600) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1336307305.

Contact Information

	Dr Douglas Matthew Weine, MD
	365 Broad St, Red Bank, NJ 07701-2150
	(732) 842-4294
	(732) 548-7408

Physician's Profile

Full Name	Dr Douglas Matthew Weine
Gender	Male
Speciality	Gastroenterology
Experience	20 Years
Location	365 Broad St, Red Bank, New Jersey
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Douglas Matthew Weine graduated from medical school in 2004

NPI Data:

NPI Number: 1336307305
Provider Enumeration Date: 05/27/2008
Last Update Date: 12/02/2014

Medicare PECOS Information:

PECOS PAC ID: 6709917164
Enrollment ID: I20100629000099

Medical Identifiers

Medical identifiers for Dr Douglas Matthew Weine such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1336307305	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RG0100X	Internal Medicine - Gastroenterology	238902 (New York)	Secondary
207RG0100X	Internal Medicine - Gastroenterology	25MA08720600 (New Jersey)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Riverview Medical Center	Red bank, NJ	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Allied Digestive Health Llc	5991027583	216

News Archive

Retirement's revolving door: Why some workers can't call it quits

In his view, Tim Franson utterly failed at retirement. After 20 years as a high-ranking vice president at drugmaker Eli Lilly, Franson and his wife, Chris, a successful real estate agent, thought they were quietly retiring nearly a decade ago to Bonita Springs, Fla.

Arizona State University and Mayo Clinic team up to explore metabolic syndrome

Arizona State University and Mayo Clinic in Arizona are joining forces in a partnership to investigate metabolic syndrome - a cluster of high-risk medical factors that include increased blood pressure, elevated insulin levels, excess body fat and abnormal cholesterol levels, which can lead to heart disease, stroke and diabetes.

FDA grants orphan-drug designation to Genoa's pirfenidone for treatment of IPF disease

Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, today announced the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation to Genoa for the use of pirfenidone in their lead program - inhaled GP-101 for the treatment of IPF.

Results from CytRx's Phase 2 STAR-1 registration clinical trial for tamibarotene announced

ytRx Corporation, a biopharmaceutical company, today announced favorable preliminary results from its Phase 2 STAR-1 registration clinical trial for tamibarotene in the treatment of acute promyelocytic leukemia (APL) in patients failing other treatments.

Targeting CDK1 pathway may be efficacious for acute myeloid leukemias with FLT3 mutation

Acute myeloid leukemia, a common leukemia in adults, is characterized by aberrant proliferation of cancerous bone marrow cells. Activating mutations in a protein receptor known as FLT3 receptor are among the most prevalent mutations observed in acute myeloid leukemias. FLT3 mutants are thought to activate several signaling pathways that contribute to cancer development.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Douglas Matthew Weine allows following entities to bill medicare on his behalf.

Entity Name	Allied Digestive Health Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1265831259 PECOS PAC ID: 5991027583 Enrollment ID: O20141210001569

News Archive

Retirement's revolving door: Why some workers can't call it quits

Arizona State University and Mayo Clinic team up to explore metabolic syndrome

FDA grants orphan-drug designation to Genoa's pirfenidone for treatment of IPF disease

Results from CytRx's Phase 2 STAR-1 registration clinical trial for tamibarotene announced

Targeting CDK1 pathway may be efficacious for acute myeloid leukemias with FLT3 mutation

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Douglas Matthew Weine is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Douglas Matthew Weine, MD 365 Broad St, Red Bank, NJ 07701-2150 Ph: (732) 842-4294	Dr Douglas Matthew Weine, MD 365 Broad St, Red Bank, NJ 07701-2150 Ph: (732) 842-4294

News Archive

Retirement's revolving door: Why some workers can't call it quits

Arizona State University and Mayo Clinic team up to explore metabolic syndrome

FDA grants orphan-drug designation to Genoa's pirfenidone for treatment of IPF disease

Results from CytRx's Phase 2 STAR-1 registration clinical trial for tamibarotene announced

Targeting CDK1 pathway may be efficacious for acute myeloid leukemias with FLT3 mutation

Internal Medicine Doctors in Red Bank, NJ

Dr. Anuradha Thalasila, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 157 Broad St Ste 317, Red Bank, NJ 07701 Phone: 732-530-2960 Fax: 732-530-7446
Dr. Khalid M Ahmad, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: One Riverview Plaza 2 West, Riverview Medical Center, Red Bank, NJ 07701 Phone: 732-530-2421
Dr. Smita N Kargutkar, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 225 Highway 35 North, Suite 102-b, Red Bank, NJ 07701 Phone: 732-413-8000 Fax: 732-400-6745
Rosemary D Gorman, APN Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 205 Rutledge Dr, Red Bank, NJ 07701 Phone: 732-687-7632 Fax: 732-796-7123
Mrs. Anca Marie Salaru, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 157 Broad St, Suite 317, Red Bank, NJ 07701 Phone: 732-530-2960 Fax: 732-530-7446
Robert John Gialanella, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 365 Broad St, Red Bank, NJ 07701 Phone: 732-842-4294 Fax: 732-842-3854
Dr. Vikranta Sharma, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 176 Riverside Ave, Red Bank, NJ 07701 Phone: 723-224-6868 Fax: 732-224-0843

Dr Douglas Matthew Weine, MD - Medicare Gastroenterology in Red Bank, NJ

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Retirement's revolving door: Why some workers can't call it quits

Arizona State University and Mayo Clinic team up to explore metabolic syndrome

FDA grants orphan-drug designation to Genoa's pirfenidone for treatment of IPF disease

Results from CytRx's Phase 2 STAR-1 registration clinical trial for tamibarotene announced

Targeting CDK1 pathway may be efficacious for acute myeloid leukemias with FLT3 mutation

Medicare Reassignments

Retirement's revolving door: Why some workers can't call it quits

Arizona State University and Mayo Clinic team up to explore metabolic syndrome

FDA grants orphan-drug designation to Genoa's pirfenidone for treatment of IPF disease

Results from CytRx's Phase 2 STAR-1 registration clinical trial for tamibarotene announced

Targeting CDK1 pathway may be efficacious for acute myeloid leukemias with FLT3 mutation

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Retirement's revolving door: Why some workers can't call it quits

Arizona State University and Mayo Clinic team up to explore metabolic syndrome

FDA grants orphan-drug designation to Genoa's pirfenidone for treatment of IPF disease

Results from CytRx's Phase 2 STAR-1 registration clinical trial for tamibarotene announced

Targeting CDK1 pathway may be efficacious for acute myeloid leukemias with FLT3 mutation

Internal Medicine Doctors in Red Bank, NJ